AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products

SP Scientific report that AstraZeneca BioPharmaceuticals R&D (Gothenburg, Sweden) has invested in a LyoConstellationTM S10 freeze dryer intended to help drive research and development of small scale GMP production. The SP Scientific LyoConstellation system is planned for use on multiple projects to support early to late phase development including GMP production of small batches for Phase 1 and Phase 2 clinical trials.

AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products

The LyoConstellation provides the flexibility in that it could be used aseptically within a GMP environment as well as for lyophilization development in relation to the small-scale manufacture of parenteral products. SP Scientific have a strong heritage in freeze-drying technology and offer a range of proprietary technological innovations such as ControLyo® controlled nucleation and TDLAS (LyoFlux®) which are proven to assist in developing challenging formulations from R&D to smaller production scale in a clinical setting.

The LyoConstellation S10 is a Line of Sight™ enabled freeze-drying system for undertaking early stage development under aseptic and controlled conditions. This means product behaves in the same manner once it is ready for scale-up and eventually ready for commercialization. Offering a capacity of 9.8 ft2 (0.85 m2) and precise shelf temperature control from -55 °C to +65 °C, the LyoConstellation S10 is designed, even when fully loaded, to hold 100 mTorr vacuum and shelf temperatures of over +40 °C enabling unmatched sublimation rates with high moisture applications with no evidence of choked flow. Isolator and cleanroom integratable, the LyoConstellation S10 is capable of clean-in-place (CIP) and steam-in-place (SIP) for aseptic manufacturing.

The LyoConstellation S10 is powerfully equipped as standard to provide very high capacity, broaden equipment capability and expand design space. Configurable with the latest technologies including SMART™ cycle optimization technology, ControLyo® Ice Nucleation Technology and LyoFlux® TDLAS (Tunable Diode Laser Absorption Spectroscopy) for vapor mass flow measurement and inference of critical data such as batch product temperature and batch Kv (vial heat transfer coefficient), the LyoConstellation S10 is able to deliver an unmatched array of process analytical data. These technology options together with the LyoS™ software platform, for working in compliance with 21 CFR Part 11, are common to the full range of SP Scientific freeze dryers enabling the same technologies and equipment to be used for both R&D and production.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SP Scientific. (2019, September 26). AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products. News-Medical. Retrieved on November 14, 2019 from https://www.news-medical.net/news/20190926/AstraZeneca-invests-in-SP-Scientific-LyoConstellation-system-to-help-drive-GMP-production-of-parenteral-products.aspx.

  • MLA

    SP Scientific. "AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products". News-Medical. 14 November 2019. <https://www.news-medical.net/news/20190926/AstraZeneca-invests-in-SP-Scientific-LyoConstellation-system-to-help-drive-GMP-production-of-parenteral-products.aspx>.

  • Chicago

    SP Scientific. "AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products". News-Medical. https://www.news-medical.net/news/20190926/AstraZeneca-invests-in-SP-Scientific-LyoConstellation-system-to-help-drive-GMP-production-of-parenteral-products.aspx. (accessed November 14, 2019).

  • Harvard

    SP Scientific. 2019. AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products. News-Medical, viewed 14 November 2019, https://www.news-medical.net/news/20190926/AstraZeneca-invests-in-SP-Scientific-LyoConstellation-system-to-help-drive-GMP-production-of-parenteral-products.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
New natural product fractions library to advance drug discovery efforts